Abstract
We describe ribavirin administration in hospitalized children over an 11-year period. Most patients were immunocompromised; there was variability in ribavirin use across hospitals. There was a clear shift toward the use of oral ribavirin despite a lack of evidence for its use.
Publication types
-
Research Support, N.I.H., Extramural
MeSH terms
-
Antiviral Agents / therapeutic use
-
Child
-
Child, Hospitalized
-
Drug Therapy, Combination
-
Humans
-
Respiratory Syncytial Virus Infections* / drug therapy
-
Ribavirin* / therapeutic use
-
Treatment Outcome
Substances
-
Antiviral Agents
-
Ribavirin